Dr. Cheryl Willman, CEO and director of the UNM Cancer Research & Treatment Center, has been appointed by the National Institutes of Health to serve as the Chairperson of the Hematology Study Section. The appointment begins on July 1, 2002 and ends on June 30, 2004.
Members are selected on the basis of their demonstrated competence and achievement in their scientific journals and other significant scientific activities, achievements and honors. Willman, who is a professor of pathology at the UNM School of Medicine, is an internationally recognized leukemia researcher. Labs at the CRTC receive samples from one-half of all children and one-third of all adults in the United States who are affected by leukemia.
The Hematology Study Section reviews applications for studies involving the basic blood system with a focus on blood formation and destruction. The chairperson contributes significantly to biomedical research efforts.